Patent · US Active

Amide derivatives as TRPV1 antagonists

US7998982B2 · kind B2 · utility

4Cited by

1References

6Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

Anil Vasudevan · Union Grove, US
Brian S. Brown · Evanston, US
Jerome F. Daanen · Racine, US
Arthur Gomtsyan · Vernon Hills, US
Tammie K. Jinkerson · Pleasant Prairie, US
Ryan G. Keddy · Beach Park, US
Michael E. Kort · Lake Bluff, US
Philip R. Kym · Libertyville, US
Mark A. Matulenko · Libertyville, US

Key dates

Filing date	Aug 8, 2008
Grant date	Aug 16, 2011
Priority date	—
Expiry date	Aug 8, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof,wherein R1, R2, and R3, are defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.